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It has been reported that various progenitor cells or stem cells
and continuously released bioactive molecules can enhance
the regeneration of muscles and thus help to treat chronic de-
generative diseases, such as urinary/fecal incontinence and
erectile dysfunction. However, the regeneration of muscles alone
cannot be a fundamental cure of chronic degenerative dis-
eases, because regenerated muscles with insufficient nerve
connections subsequently lead to muscle atrophy [1].To prevent
the atrophy and maintain the function of the regenerated
muscles, the reinnervation of muscles by appropriate nerves
is an essential parameter. Therefore, the use of various stem
cells combined with bioactive molecules which can induce neu-
rogenic differentiation and thus enhance nerve regeneration,
may be additional biological cues for the restoration of healthy
muscles. On the basis of the literatures, it was expected that
if a biological cues [i.e., stem cells or growth factors (GFs) for
nerve restoration]-loaded matrix system could be properly pre-
pared, it may be very helpful to prevent the atrophy of
regenerated muscles by sufficient reinnervation, and thus can
be a fundamental therapy for chronic degenerative diseases.
In this study, growth factors [basic fibroblast growth factor (bFGF)
and/or nerve growth factor (NGF)]-immobilized polycaprolactone
(PCL)/Pluronic F127 microspheres were prepared using an iso-
lated particulate-melting method [2] and the sequential binding
of heparin and growth factors (GFs) onto the microspheres [3].
The GFs immobilized on the microspheres were released in a
sustained manner over 28 days, regardless of GF type (Fig. 1).
From the in vitro culture of muscle-derived stem cells, it was
observed that the NGF-immobilizedmicrospheres inducedmore
neurogenic differentiation than the bFGF-immobilized
microspheres, as evidenced by a quantitative real time poly-
merase chain reaction using specific neurogenic markers
(Nestin, GFAP, β-tubulin, and MAP2) andWestern blot (markers,
Nestin and β-tubulin) analyses.The dual bFGF/NGF-immobilized
microspheres showed better neurogenic differentiation than
the microspheres immobilized with single bFGF or NGF. From
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the preliminary animal study, the dual bFGF/NGF-immobilized
microsphere group also showed effective nerve regeneration,
as evaluated by immunocytochemistry using a marker,
β-tubulin. The dual bFGF/NGF-immobilized PCL/Pluronic F127
microspheres may be a promising candidate for nerve regen-
eration in certain target tissues (i.e., muscles) leading to
sufficient reinnervation.
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Fig. 1 – Cumulative released amount of growth factors on the PCL/F127 microspheres with and without heparin (n = 3,
*p < 0.05).
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